These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28529546)

  • 1. Disease management programs for patients with type 2 diabetes mellitus in Germany: a longitudinal population-based descriptive study.
    Mehring M; Donnachie E; Bonke FC; Werner C; Schneider A
    Diabetol Metab Syndr; 2017; 9():37. PubMed ID: 28529546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease management programs for patients with COPD in Germany: a longitudinal evaluation of routinely collected patient records.
    Mehring M; Donnachie E; Fexer J; Hofmann F; Schneider A
    Respir Care; 2014 Jul; 59(7):1123-32. PubMed ID: 24222706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease management programs for patients with asthma in Germany: a longitudinal population-based study.
    Mehring M; Donnachie E; Mutschler R; Hofmann F; Keller M; Schneider A
    Respir Care; 2013 Jul; 58(7):1170-7. PubMed ID: 23106942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences.
    Schäfer I; Küver C; Gedrose B; Hoffmann F; Russ-Thiel B; Brose HP; van den Bussche H; Kaduszkiewicz H
    BMC Health Serv Res; 2010 Mar; 10():55. PubMed ID: 20199685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Nonfatal Stroke in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison Between Disease Management Programs and Standard Care.
    Wiefarn S; Heumann C; Rettelbach A; Kostev K
    J Diabetes Sci Technol; 2017 Jul; 11(4):808-813. PubMed ID: 28300432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
    Drabik A; Graf C; Büscher G; Stock S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study.
    Laxy M; Stark R; Meisinger C; Kirchberger I; Heier M; von Scheidt W; Holle R
    Diabetol Metab Syndr; 2015; 7():77. PubMed ID: 26388948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].
    Joos S; Rosemann T; Heiderhoff M; Wensing M; Ludt S; Gensichen J; Kaufmann-Kolle P; Szecsenyi J
    BMC Public Health; 2005 Oct; 5():99. PubMed ID: 16202151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No selection, but higher satisfaction of people participating in the disease management programme diabetes type 2 in Germany.
    Kellner C; Kuniss N; Kloos C; Müller UA; Müller N
    Acta Diabetol; 2018 Apr; 55(4):363-367. PubMed ID: 29383585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a survival benefit within a German primary care-based disease management program?
    Miksch A; Laux G; Ose D; Joos S; Campbell S; Riens B; Szecsenyi J
    Am J Manag Care; 2010 Jan; 16(1):49-54. PubMed ID: 20148605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rigid RSA DMP for Type-2 Diabetes Mellitus: results of a three-state survey].
    Schulze J; Rothe U; Müller G; Kunath H;
    Z Arztl Fortbild Qualitatssich; 2005; 99(3):227-31. PubMed ID: 15999587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and determinants of new first-line antihyperglycaemic drug use in patients with type 2 diabetes mellitus.
    Geier AS; Wellmann I; Wellmann J; Kajüter H; Heidinger O; Hempel G; Hense HW
    Diabetes Res Clin Pract; 2014 Oct; 106(1):73-80. PubMed ID: 25139631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-Diabetic Medication During the First Four Years of Treatment. A Study Based on Claims Data].
    Lappe V; Köster I; Schubert I
    Dtsch Med Wochenschr; 2017 Jan; 142(1):e1-e9. PubMed ID: 28056470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis.
    Drabik A; Büscher G; Thomas K; Graf C; Müller D; Stock S
    Popul Health Manag; 2012 Aug; 15(4):241-7. PubMed ID: 22401149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ambulatory care of patients with asthma in Germany and disease management program for asthma from the view of statutory health insured patients. A postal survey of statutory health insured patients].
    Bücker B; Löscher S; Schürer C; Schaper K; Abholz HH; Wilm S
    Dtsch Med Wochenschr; 2015 Mar; 140(6):e60-6. PubMed ID: 25774739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease management programs in type 2 diabetes: quality of care.
    Berthold HK; Bestehorn KP; Jannowitz C; Krone W; Gouni-Berthold I
    Am J Manag Care; 2011 Jun; 17(6):393-403. PubMed ID: 21756010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Which patients are (not) included in the DMP diabetes programme?].
    Dunkelberg S; Zingel D; Noack A; van den Bussche H; Kaduszkiewicz H
    Gesundheitswesen; 2006 May; 68(5):289-93. PubMed ID: 16773549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guideline compliance in the treatment of patients with chronic heart failure through family doctor-centred health care: results of an evaluation study].
    Roehl I; Beyer M; Gondan M; Rochon J; Bauer E; Kaufmann-Kolle P; Gerlach FM
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(6):394-402. PubMed ID: 24075681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany.
    Gitt AK; Sonntag F; Jannowitz C; Weizel A; Karmann B; Schaefer JR; Pittrow D; Hildemann SK
    Curr Med Res Opin; 2016; 32(3):417-26. PubMed ID: 26568400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.